Resultats de la cerca - Eric D. Jacobsen

Refinar resultats
  1. 1
    Follicular lymphoma: 2023 update on diagnosis and management

    Follicular lymphoma: 2023 update on diagnosis and management per Eric D. Jacobsen

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Follicular lymphoma: 2020 update on diagnosis and management

    Follicular lymphoma: 2020 update on diagnosis and management per Arnold S. Freedman, Eric D. Jacobsen

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Rosai–Dorfman Disease with Activating <i>KRAS</i> Mutation — Response to Cobimetinib

    Rosai–Dorfman Disease with Activating <i>KRAS</i> Mutation — Response to Cobimetinib per Eric D. Jacobsen, Vignesh Shanmugam, Jyothi P. Jagannathan

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  4. 4
    2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

    2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) per Mark W. Clemens, Eric D. Jacobsen, Steven M. Horwitz

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Concepts of Intrinsic Value and Integrity of Plants in Organic Plant Breeding and Propagation

    Concepts of Intrinsic Value and Integrity of Plants in Organic Plant Breeding and Propagation per E. Lammerts Van Bueren, P.C. Struik, M. Tiemens‐Hulscher, Eric D. Jacobsen

    Publicat 2003
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine

    Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine per Monica Fung, Eric D. Jacobsen, Arnold S. Freedman, Daniel Prestes, Dimitrios Farmakiotis, Xiangmei Gu, Paul L. Nguyen, Sophia Koo

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma

    Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma per Vignesh Shanmugam, Gabriel K. Griffin, Eric D. Jacobsen, Christopher D.�M. Fletcher, Lynette M. Sholl, Jason L. Hornick

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma

    Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma per Michael Crump, Bertrand Coiffier, Eric D. Jacobsen, Linda Sun, Justin L. Ricker, Huafeng Xie, Stanley R. Frankel, Sophia Randolph, Bruce D. Cheson

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin

    Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin per Steven M. Horwitz, Ranjana H. Advani, Nancy L. Bartlett, Eric D. Jacobsen, Jeff P. Sharman, Owen A. O’Connor, Tanya Siddiqi, Dana A. Kennedy, Yasuhiro Oki

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome

    A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome per Eric D. Jacobsen, H. T. Kim, Vincent T. Ho, Corey Cutler, John Koreth, David C. Fisher, Philippe Armand, Edwin P. Alyea, Arnold S. Freedman, RJ Soiffer, Joseph H. Antin

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

    Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimul... per John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard T. Maziarz, Eric D. Jacobsen, Auayporn Nademanee, John M. McCarty, Gary Bridger, Gary Calandra

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma

    Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma per Deepa Jagadeesh, Steve Horwitz, Nancy L. Bartlett, Hyun Soo Kim, Eric D. Jacobsen, Madeleine Duvic, Meredith Little, William L. Trepicchio, Keenan Fenton, Matthew Onsum, Julie Lisano, Ranjana H. Advani

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Prognostic factors for patients with diffuse large <scp>B</scp> cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era

    Prognostic factors for patients with diffuse large <scp>B</scp> cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emis... per Philippe Armand, Sarah A. Welch, Haesook T. Kim, Ann S. LaCasce, Eric D. Jacobsen, Matthew S. Davids, Caron A. Jacobson, David C. Fisher, Jennifer R. Brown, Erin Coughlin, Arnold S. Freedman, Yi‐Bin Chen

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

    Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma per Jeffrey A. Barnes, Eric D. Jacobsen, Yang Feng, AS Freedman, Ephraim P. Hochberg, Ann S. LaCasce, Philippe Armand, Robin Joyce, Aliyah R. Sohani, Scott J. Rodig, Donna Neuberg, David C. Fisher, Jeremy S. Abramson

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression

    Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression per Eric D. Jacobsen, Jeff P. Sharman, Yasuhiro Oki, Ranjana H. Advani, Jane N. Winter, Celeste M. Bello, Gary Spitzer, Maria Corinna Palanca-Wessels, Dana A. Kennedy, Pamela Levine, Jing Yang, Nancy L. Bartlett

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Ventricular arrhythmias and sudden death in patients taking ibrutinib

    Ventricular arrhythmias and sudden death in patients taking ibrutinib per Benjamin L. Lampson, Lijian Yu, Robert J. Glynn, Jacqueline C. Barrientos, Eric D. Jacobsen, Versha Banerji, Jeffrey A. Jones, Renata Walewska, Kerry J. Savage, Gregory F. Michaud, Javid J. Moslehi, Jennifer R. Brown

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  17. 17
    A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

    A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma per Thomas E. Witzig, Craig B. Reeder, Betsy LaPlant, Mamta Gupta, Patrick B. Johnston, Ivana N. Micallef, Luis F. Porrata, Stephen M. Ansell, Joseph P. Colgan, Eric D. Jacobsen, Irene M. Ghobrial, Thomas M. Habermann

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome

    Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome per Philippe Armand, Haesook T. Kim, Vincent T. Ho, Corey Cutler, John Koreth, Joseph H. Antin, Ann S. LaCasce, Eric D. Jacobsen, David C. Fisher, Jennifer R. Brown, George P. Canellos, Arnold S. Freedman, Robert J. Soiffer, Edwin P. Alyea

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

    Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia per Philip C. Amrein, Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy, David C. Fisher, Ann S. LaCasce, Eric D. Jacobsen, Philippe Armand, Robert P. Hasserjian, Lillian Werner, Donna Neuberg, Jennifer R. Brown

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma

    A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma per Philippe Armand, Robert Redd, Jad Bsat, Sangeetha Mayuram, Angela Giardino, David C. Fisher, Ann S. LaCasce, Caron A. Jacobson, Matthew S. Davids, Jennifer R. Brown, Li Weng, Jennifer Wilkins, Malek Faham, Arnold S. Freedman, Robin Joyce, Eric D. Jacobsen

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: